EPS HEALTH TECH (03860) announces expected mid-term net profit of approximately HK$16 million, turning losses into gains year-on-year.

EPS Health Tech (03860) announced that the group is expected to achieve unaudited net profit of approximately HK$16 million for the six-month period ending on September 30, 2024, compared to an unaudited net loss of approximately HK$8.7 million for the six-month period ending on September 30, 2023. The expected improvement is mainly attributed to (i) fair value gains on bills of exchange generated by non-controlling interests; (ii) an increase in profits from the healthcare products business; and (iii) a reduction in administrative and research and development expenses due to cost-saving measures implemented by the group.